Journal of Emergency Nursing, published by Elsevier Science Inc, serves as a premier platform for advancing the field of emergency nursing. Since its inception in 1975, this peer-reviewed journal has established itself as a vital resource for researchers, practitioners, and educators alike, with a notable impact factor and current ranking of #8 out of 32 in the Emergency Nursing category, placing it in the 76th percentile. The journal's commitment to the dissemination of high-quality evidence, innovative practices, and essential insights makes it an indispensable tool for those seeking to excel in acute care settings. Although not open access, the Journal of Emergency Nursing is dedicated to fostering knowledge and improving patient outcomes through robust research and comprehensive reviews, aligning closely with its mission to enhance emergency nursing practices and education through every issue until 2024 and beyond. For professionals and students keen on staying at the forefront of emergency care advancements, this journal provides a wealth of knowledge and resources, reflecting the critical issues and developments shaping the future of healthcare.

Welcome to the JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, a premier academic publication focused on the advancing field of anesthesiology with a particular emphasis on cardiothoracic and vascular procedures. Published by W B SAUNDERS CO-ELSEVIER INC, this esteemed journal provides critical insights and discoveries that shape the practices of anesthesiologists and cardiovascular specialists. With an impressive impact factor that reflects its robust presence in the academic community, the journal has been ranked in the Q1 quartile for Anesthesiology and Pain Medicine and Q2 for Cardiology and Cardiovascular Medicine as of 2023. Spanning over three decades since its inception in 1991, it offers a vital platform for the dissemination of pioneering research, clinical studies, and practice guidelines. Researchers, clinicians, and students alike will find valuable content that addresses the complexity and nuances of perioperative anesthetic care, ultimately enhancing patient outcomes. This journal is a repository of knowledge aimed at fostering innovation and excellence in the dynamic fields of cardiothoracic and vascular anesthesia.

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

The Journal of Health Organization and Management, published by Emerald Group Publishing Ltd, serves as a pivotal resource for professionals, researchers, and students interested in the intersection of health policy and organizational effectiveness. With an ISSN of 1477-7266 and an E-ISSN of 1758-7247, this esteemed journal has been charting advancements in health management since 2003, showcasing articles that reflect rigorous research and the latest trends in the field. Hailing from the United Kingdom, the journal has established itself within the upper echelons of academic literature, currently enjoying a Q2 classification in notable categories, including Business, Management, and Accounting, Health Policy, and Organizational Behavior and Human Resource Management, as of 2023. With impressive rankings in Scopus, including a percentile rank in the 62nd for Business and Management, it is an essential platform for disseminating innovative ideas and evidence-based findings crucial for enhancing health care systems globally. While it operates under a conventional access model, the journal remains dedicated to fostering scholarly dialogue and advancing the understanding of health organization complexities.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

Internal and Emergency Medicine is a highly regarded academic journal published by Springer-Verlag Italia SRL, dedicated to advancing the fields of emergency medicine and internal medicine. With an impressive Q1 ranking in Emergency Medicine and a Q2 ranking in Internal Medicine as of 2023, the journal serves as a vital platform for researchers and professionals alike seeking to disseminate pioneering findings and innovative practices. Established in 2006 and operational until 2024, the journal focuses on the intersection of these critical medical domains, providing insight into urgent clinical challenges and everyday internal medicine cases. Although currently not open access, it offers subscription options for readers aiming to deepen their knowledge in these essential areas of healthcare. The journal’s contributions are instrumental in shaping medical protocols and enriching the education of students and practitioners globally, all while based in the heart of Italy, specifically Milan.

BMJ Open Quality, published by the esteemed BMJ Publishing Group, is an influential open access journal that has been a vital platform for advancing the quality of healthcare since its inception in 2017. Based in the United Kingdom, this journal focuses on a diverse range of topics within health policy, leadership and management, and public health, catering specifically to professionals, researchers, and students eager to explore the intersection of quality improvement and healthcare delivery. With an impressive ranking in Scopus categories, including Q2 in Health Policy and Leadership and Management, BMJ Open Quality fosters a multidisciplinary dialogue that addresses the pressing challenges facing the healthcare sector today. Researchers will find robust access options, allowing for unrestricted sharing of valuable findings, thereby enhancing collaboration and innovation in the field. Positioned at the forefront of quality enhancement methodologies, BMJ Open Quality is indispensable for those dedicated to driving systematic changes in health services.

Journal of Patient Safety and Risk Management, published by SAGE Publications Ltd, stands as a vital resource for the exploration and discourse surrounding safety and risk in healthcare environments. Established in 2018 and continuing through 2024, this journal delivers a rich repository of knowledge aimed at improving patient safety protocols and mitigating risks within healthcare systems. With an ISSN of 2516-0435 and an E-ISSN of 2516-0443, the journal is indexed in several categories with a notable performance in Health Policy and Health (social science), rated in Q3, while also addressing Leadership and Management in Q4. Despite the absence of an open access model, the journal provides a platform for researchers, healthcare professionals, and students to stay informed about the latest developments and evidence-based practices within the dynamically evolving landscape of patient safety. Given its Scopus rankings, which include a percentile of 46th in Health (social science) and 36th in Health Policy, the journal is positioned as a credible and impactful publication for those dedicated to enhancing patient care through robust risk management strategies.

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.